Onco Surgery Days Webinar Series-II; Hepatocellular Carcinoma What’s New (Next and Beyond)
It is our great honor and privilege to invite all of you to the Onco Surgery Days Webinar Series II that will be held on December 19th. The topic of the meeting will be “Hepatocellular Carcinoma What’s New? (Next and Beyond)”.
We are proud that the meeting will have the endorsement of the IASGO.
Onco Surgery Days Webinar Series-II; Hepatocellular Carcinoma What’s New (Next and Beyond)
Başlangıç Tarihi:
19.12.2020 @ 15:30
Bitiş Tarihi:
19.12.2020 @ 19:30
It is our great honor and privilege to invite all of you to the Onco Surgery Days Webinar Series II that will be held on December 19th. The topic of the meeting will be “Hepatocellular Carcinoma What’s New? (Next and Beyond)”. We are proud that the meeting will have the endorsement of the IASGO. In the last decade, several new technologies and medical therapies have been introduced to modify, improve and expand the curative options for HCC patients. During the meeting, international experts in the medical and surgical management of HCC will present the current landscape for the treatment of HCC.
The meeting wants to include all the physicians involved in the clinical management of HCC patients as surgeons, hepatologists, gastroenterologist, radiologists, oncologists, and nuclear medicine. The personalized treatment of each single HCC patient requires and is not possible without the participation of different specialists in a multidisciplinary setting.
Onco Surgery Days Webinar Series-II; Hepatocellular Carcinoma What’s New (Next and Beyond)
Başlangıç Tarihi:
19.12.2020 @ 15:30
Bitiş Tarihi:
19.12.2020 @ 19:30
It is our great honor and privilege to invite all of you to the Onco Surgery Days Webinar Series II that will be held on December 19th. The topic of the meeting will be “Hepatocellular Carcinoma What’s New? (Next and Beyond)”. We are proud that the meeting will have the endorsement of the IASGO. In the last decade, several new technologies and medical therapies have been introduced to modify, improve and expand the curative options for HCC patients. During the meeting, international experts in the medical and surgical management of HCC will present the current landscape for the treatment of HCC.
The meeting wants to include all the physicians involved in the clinical management of HCC patients as surgeons, hepatologists, gastroenterologist, radiologists, oncologists, and nuclear medicine. The personalized treatment of each single HCC patient requires and is not possible without the participation of different specialists in a multidisciplinary setting.